Learn more

PHARMAGENICS INC

Overview
  • Total Patents
    37
About

PHARMAGENICS INC has a total of 37 patent applications. Its first patent ever was published in 1992. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, organic fine chemistry and environmental technology are NIPPON ALUMINUM ALKYLS LTD, ABELLO PASCUAL JUAN and OPAL DRUG DISCOVERY LTD.

Patent filings per year

Chart showing PHARMAGENICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cook Alan F 19
#2 Beutel Bruce A 16
#3 Bertelsen Arthur H 14
#4 Fathi Reza 12
#5 Coppola George R 9
#6 Beaudry Gary A 7
#7 Sherman Michael I 7
#8 Gao Hetian 6
#9 Gentles Robert G 4
#10 Joesten Michael E 4

Latest patents

Publication Filing date Title
AU3228197A Cell growth regulatory genes
WO9728168A1 Non-nucleotide phosphorous ester oligomers
CA2244924A1 Non-nucleotide phosphorous ester oligomers
AU3636995A Bridged and unbridged quadruplex/duplex oligonucleotides
EP0754238A1 Determination and identification of active compounds in a compound library
AU7717094A Methods for isolation of most abundant oligonucleotides from complex mixtures
WO9500528A1 Inhibition of basic fibroblast growth factor with oligonculeotides
AU7112594A Method for selection of targets and nucleic acids which modulate target activity
AU7175094A Inhibition of interferon-gamma with oligonucleotides
AU7102594A Oligonucleotides which inhibit hiv protease function
US5599917A Inhibition of interferon-γ with oligonucleotides
CA2153057A1 Novel oligonucleotides modified with non-nucleotide bridging groups
WO9323570A1 Oligonucleotides having conjugates attached at the 2'-position of the sugar moiety
EP0641354A1 Oligonucleotides having aminohydrocarbon phosphonate moieties.
WO9310140A1 Oligonucleotides having modified anionic moieties